CoChat
Sign Up
Cited by 41

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates

Wang, Min, Arnsten, Amy F. T.·2015·Neuroscience Bulletin
DOI 10.1007/s12264-014-1504-6PMC PMC4734117
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12264-014-1504-6

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 10 references

Research works printed but not linked: 48

  1. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 1999, 51: 7–61. · DOI · Paper page
  2. Erreger K, Dravid SM, Banke TG, Wyllie DJ, Traynelis SF. Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Physiol 2005, 563: 345–358. · DOI
  3. Kristiansen LV, Bakir B, Haroutunian V, Meador-Woodruff JH. Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia. Schizophr Res 2010, 119: 198–209. · DOI
  4. Kurup P, Zhang Y, Xu J, Venkitaramani DV, Haroutunian V, Greengard P, et al. Abeta-mediated NMDA receptor endocytosis in Alzheimer’s disease involves ubiquitination of the tyrosine phosphatase STEP61. J Neurosci 2010, 30: 5948–5957. · DOI
  5. Preuss T. Do rats have prefrontal cortex? The Rose-Woolsey-Akert program reconsidered. J Cognit Neurosci 1995, 7: 1–26. · DOI · Paper page
  6. Goldman-Rakic PS. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 1994, 6: 348–357. · DOI · Paper page
  7. Lim HK, Juh R, Pae CU, Lee BT, Yoo SS, Ryu SH, et al. Altered verbal working memory process in patients with Alzheimer’s disease: an fMRI investigation. Neuropsychobiology 2008, 57: 181–187. · DOI
  8. Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 2004, 304: 1021–1024. · DOI
  9. Cho KK, Khibnik L, Philpot BD, Bear MF. The ratio of NR2A/B NMDA receptor subunits determines the qualities of ocular dominance plasticity in visual cortex. Proc Natl Acad Sci U S A 2009, 106: 5377–5382. · DOI
  10. Yuste R, Bonhoeffer T. Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci 2001, 24: 1071–1089. · DOI · Paper page
  11. Tashiro A, Yuste R. Regulation of dendritic spine motility and stability by Rac1 and Rho kinase: evidence for two forms of spine motility. Mol Cell Neurosci 2004, 26: 429–440. · DOI
  12. Araya R, Jiang J, Eisenthal KB, Yuste R. The spine neck filters membrane potentials. Proc Natl Acad Sci U S A 2006, 103: 17961–17966. · DOI · Paper page
  13. Goebel-Goody SM, Davies KD, Alvestad Linger RM, Freund RK, Browning MD. Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices. Neuroscience 2009, 158: 1446–1459. · DOI
  14. Baez MV, Oberholzer MV, Cercato MC, Snitcofsky M, Aguirre AI, Jerusalinsky DA. NMDA receptor subunits in the adult rat hippocampus undergo similar changes after 5 minutes in an open field and after LTP induction. PLoS One 2013, 8: e55244. · DOI
  15. Shipton OA, Paulsen O. GluN2A and GluN2B subunit-containing NMDA receptors in hippocampal plasticity. Philos Trans R Soc Lond B Biol Sci 2013, 369: 20130163. · DOI · Paper page
  16. Dupuis JP, Ladépêche L, Seth H, Bard L, Varela J, Mikasova L, et al. Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses. EMBO J 2014, 33: 842–861. · DOI
  17. Liu XB, Murray KD, Jones EG. Switching of NMDA receptor 2A and 2B subunits at thalamic and cortical synapses during early postnatal development. J Neurosci 2004, 24: 8885–8895. · DOI
  18. Philpot BD, Weisberg MP, Ramos MS, Sawtell NB, Tang YP, Tsien JZ, et al. Effect of transgenic overexpression of NR2B on NMDA receptor function and synaptic plasticity in visual cortex. Neuropharmacology 2001, 41: 762–770. · DOI
  19. Goldman PS, Rosvold HE. Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. Exp Neurol 1970, 27: 291–304. · DOI
  20. Funahashi S, Bruce CJ, Goldman-Rakic PS. Mnemonic coding of visual space in the monkey’s dorsolateral prefrontal cortex. J. Neurophysiology 1989, 61: 331–349. · DOI · Paper page
  21. Goldman-Rakic PS. The “psychic cell” of Ramón y Cajal. Prog Brain Res 2002, 136: 427–434. · DOI
  22. Goldman-Rakic PS. Cellular basis of working memory. Neuron 1995, 14: 477–485. · DOI · Paper page
  23. Wang XJ. Synaptic basis of cortical persistent activity: the importance of NMDA receptors to working memory. J Neurosci 1999, 19: 9587–9603. · DOI · Paper page
  24. Wang XJ. Synaptic reverberation underlying mnemonic persistent activity. Trends in Neurosci 2001, 24: 455–463. · DOI · Paper page
  25. Wang MJ, Yang Y, Wang CJ, Gamo NJ, Jin LE, Mazer JA, et al. NMDA receptors subserve working memory persistent neuronal firing In dorsolateral prefrontal cortex. Neuron 2013, 77: 736–749. · DOI · Paper page
  26. Yang Y, Paspalas CD, Jin LE, Picciotto MR, Arnsten AFT, Wang M. Nicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex. Proc Nat Acad Sci USA 2013, 110: 12078–83. · DOI · Paper page
  27. Javitt DC. Glutamatergic theories of schizophrenia. Isr J Psychiatry Relat Sci 2010, 47: 4–16.
  28. Banerjee A, Macdonald ML, Borgmann-Winter KE, Hahn CG. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome. Brain Res Bull 2010, 30: 132–139. · DOI
  29. Martin LF, Freedman R. Schizophrenia and the alpha7 nicotinic acetylcholine receptor. Int Rev Neurobiol 2007, 78: 225–246. · DOI · Paper page
  30. Kristiansen LV, Patel SA, Haroutunian VH, Meador-Woodruff JH. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse 2010, 64: 495–502. · DOI
  31. Weickert CS, Fung SJ, Catts VS, Schofield PR, Allen KM, Moore LT, et al. Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia. Mol Psychiatry 2013, 18: 1185–1192. · DOI
  32. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511: 421–427. · DOI · Paper page
  33. Jackson ME, Homayoun H, Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci U S A 2004, 101: 8467–8472. · DOI · Paper page
  34. Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, et al. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 1997, 17: 141–150. · DOI
  35. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000, 47: 351–354. · DOI · Paper page
  36. Zarate CAJ, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-Daspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006, 63: 856–864. · DOI · Paper page
  37. Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 2013, 170: 1134–1142. · DOI · Paper page
  38. Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 2013, 74: 250–256. · DOI · Paper page
  39. Clark P. Treatment-refractory depression: A case of successful treatment with intranasal ketamine 10%. Ann Clin Psychiatry 2014, 26: 145.
  40. Lapidus KA, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L, et al. A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry 2014, 76: 970–976.. · DOI · Paper page
  41. Salvadore G, Cornwell BR, Colon-Rosario V, Coppola R, Grillon C, Zarate CAJ, et al. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry 2009, 65: 289–295. · DOI · Paper page
  42. Seo H, Lee D. Behavioral and neural changes after gains and losses of conditioned reinforcers. J Neurosci 2009, 29: 3627–3641. · DOI
  43. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45: 651–660. · DOI · Paper page
  44. Li N, Lee BT, Liu RJ, Banasr M, Dwyer JM, Iwata M, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329: 959–964. · DOI · Paper page
  45. Andolfatto G, Willman E, Joo D, Miller PL, Wong WB, Koehn M, et al. Intranasal ketamine for analgesia in the emergency department: a prospective observational series. Acad Emerg Med 2013, 20: 1050–1054. · DOI
  46. Vogt BA, Sikes RW. The medial pain system, cingulate cortex, and parallel processing of nociceptive information. Prog Brain Res 2000, 22: 223–235. · DOI
  47. Yeaman F, Meek R, Egerton-Warburton D, Rosengarten P, Graudins A. Sub-dissociative-dose intranasal ketamine for moderate to severe pain in adult emergency department patients. Emerg Med Australas 2014, 26: 237–242. · DOI
  48. McCarty EC, Mencio GA, Walker LA, Green NE. Ketamine sedation for the reduction of children’s fractures in the emergency department. J Bone Joint Surg Am 2000, 82-A: 912–918. · DOI

Cited by

Sorted by citations

See all 41

Metadata

Authors
Wang, M., & Arnsten, A. F. T.
Venue
Neuroscience Bulletin
Publisher
Springer Science and Business Media LLC
Published
2015-03-09
Volume
31
Issue
2
Pages
191-197
ISSN
  • 1673-7067
  • 1995-8218
DOI
10.1007/s12264-014-1504-6
PMC
PMC4734117
Cited by
41
References
10
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review